Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D

Key Points

• To evaluate national insurance coverage patterns and out-of-pocket expenses for the heart failure medication sacubitril/valsartan among Medicare Part D beneficiaries.
• Analyzed national Medicare Part D prescription formulary files and cost-sharing structures for sacubitril/valsartan.